Skip to main content

Advertisement

SpringerLink
Log in

Conference report and introduction to the symposium papers

  • Meeting Report
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Watson NF, Durrant LG, Madjd Z, Ellis IO, Scholefield JH, Spendlove I (2005) Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients. Cancer Immunol Immunother. DOI 10.1007/s00262-005-0055-0

  2. Pawelec G, Koch S, Griesemann H, Rehbein A, Hahnel K, Gouttefangeas C (2005) Immunosenescence, suppression and tumour progression. Cancer Immunol Immunother. DOI 10.1007/s00262-005-0109-3

  3. Spendlove I, Ramage JM, Bradley R, Harris C, Durrant LG (2006) Complement decay accelerating factor (DAF)/CD55 in Cancer. Cancer Immunol Immunother (in press)

  4. Miles AK, Matharoo-Ball B, Li G, Ahmad M, Rees RC (2006) The identification of human tumour antigens: current status and future developments. Cancer Immunol Immunother. DOI 10.1007/s00262-005-0115-5

  5. Ramage JM, Spendlove I, Rees R, Moss RS, Durrant LG (2006) The use of reverse immunology to identify HLA-A2 binding epitopes in Tie-2. Cancer Immunol Immunother. DOI 10.1007/s00262-005-0119-1

  6. Lopes L, Fletcher K, Ikeda Y, Collins M (2005) Lentiviral vector expression of tumour antigens in dendritic cells as an immunotherapeutic strategy. Cancer Immunol Immunother. DOI 10.1007/s00262-005-0095-5

  7. Chan L, Hardwick NR, Giunn B-A, Darling D, Gaken J, Galea-Lauri J, Ho AY, Mufti GJ, Farzaneh F (2006) An immune edited tumour versus a tumour edited immune system: prospects for immune therapy of acute myeloid leukaemia. Cancer Immunol Immunother (in press)

  8. Whelan MA, Dalgleish AG (2006) Cancer vaccines as a therapeutic modality; the long trek. Cancer Immunol Immunother (in press)

Download references

Author information

Authors and Affiliations

  1. Academic Department of Clinical Oncology, Institute of Infection, Immunity and Inflammation, University of Nottingham, City Hospital, NG5 1PB, Nottingham, UK

    L. G. Durrant

Authors
  1. L. G. Durrant
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. G. Durrant.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Durrant, L. Conference report and introduction to the symposium papers. Cancer Immunol Immunother 55, 970–972 (2006). https://doi.org/10.1007/s00262-006-0144-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-006-0144-8

Keywords

Search

Navigation